Adipokines

• New predictors of the metabolic syndrome in children-role of adipocytokines.
  Korner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W.
  Pediatr Res. 2007 Apr 5
  View
• A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: The ACCLAIM trial rationale and design.
  Torre-Amione G, Bourge RC, Colucci WS, Greenberg B, Pratt C, Rouleau JL, Sestier F, Moye LA, Geddes JA, Nemet AJ, Young JB; for the ACCLAIM investigators.
  Can J Cardiol. 2007 Apr;23(5):369-76.
  View

Adipose Tissue Disorders

• Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
  Shimabukuro M, Tanaka H, Shimabukuro T.
  J Hypertens. 2007 Apr;25(4):841-8.
  View
• A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome.
  Gong W, Ren H, Tong H, Shen X, Luo J, Chen S, Lai J, Chen X, Chen H, Yu W.
  Asia Pac J Clin Nutr. 2007 Apr;16(S1):339-345.
  View

Cardiovascular Disease

• Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
  Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.
  Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.
  View
• Association among C-reactive protein, fatty liver disease, and cardiovascular risk.
  Lizardi-Cervera J, Chavez-Tapia NC, Perez-Bautista O, Ramos MH, Uribe M.
  Dig Dis Sci. 2007 Apr 10
  View
• Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
  DECODE Study Group.
  Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):192-9.
  View

Diabetes

• Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
  Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.
  Nutr Metab Cardiovasc Dis. 2007 Apr 7
  View
• Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) Study.
  Hanefeld M, Koehler C, Gallo S, Benke I, Ott P.
  Cardiovasc Diabetol. 2007 Apr 26;6(1):13
  View

Diet, Nutrition and Metabolism

• Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function.
  Nicolson GL.
  J Cell Biochem. 2007 Apr 15;100(6):1352-69.
  View
• Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study.
  Snijder MB, van der Heijden AA, van Dam RM, Stehouwer CD, Hiddink GJ, Nijpels G, Heine RJ, Bouter LM, Dekker JM.
  Am J Clin Nutr. 2007 Apr;85(4):989-95.
  View

Drug Therapy

• The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH.
  van der Klaauw AA, Biermasz NR, Feskens EJ, Bos MB, Smit JW, Roelfsema F, Corssmit EP, Pijl H, Romijn JA, Pereira AM.
  Eur J Endocrinol. 2007 Apr;156(4):455-62.
  View
• Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
  Kintscher U, Bramlage P, Paar WD, Thoenes M, Unger T.
  Cardiovasc Diabetol. 2007 Apr 3;6:12.
  View

Epidemiology

• Metabolic syndrome in African Americans: implications for preventing coronary heart disease.
  Clark LT, El-Atat F.
  Clin Cardiol. 2007 Apr;30(4):161-4.
  View
• The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
  Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J.
  Eur Heart J. 2007 Apr;28(7):857-64.
  View
• Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.
  Ajjan R, Carter AM, Somani R, Kain K, Grant PJ.
  J Thromb Haemost. 2007 Apr;5(4):754-60.
  View
• Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
  Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J; International Diabetes Federation.
  Metabolism. 2007 Apr;56(4):552-8.
  View
• Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I.
  Empana JP, Duciemetiere P, Balkau B, Jouven X.
  Eur Heart J. 2007 May;28(9):1149-54.
  View

Exercise & Physical Activity

• Relationship of physical activity, fitness, and fatness with clustered metabolic risk in children and adolescents: the European youth heart study.
  Rizzo NS, Ruiz JR, Hurtig-Wennlof A, Ortega FB, Sjostrom M.
  J Pediatr. 2007 Apr;150(4):388-94.
  View
• Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome.
  Santos AC, Ebrahim S, Barros H.
  Prev Med. 2007 Apr;44(4):328-34.
  View
• Relationship of physical activity, fitness, and fatness with clustered metabolic risk in children and adolescents: the European youth heart study.
  Rizzo NS, Ruiz JR, Hurtig-Wennlof A, Ortega FB, Sjostrom M.
  J Pediatr. 2007 Apr;150(4):388-94.
  View

Genetics

• FXR: a promising target for the metabolic syndrome?
  Cariou B, Staels B.
  Trends Pharmacol Sci. 2007 May;28(5):236-243.
  View
• Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
  Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jorgensen T, Schmitz O, Hansen T, Pedersen O.
  Diabetologia. 2007 Jun;50(6):1201-8.
  View

Hypertension

• Hypertension and fatty liver: guilty by association?
  Brookes MJ, Cooper BT.
  J Hum Hypertens. 2007 Apr;21(4):264-70.
  View
• High blood pressure in pregnancy and coronary calcification.
  Sabour S, Franx A, Rutten A, Grobbee DE, Prokop M, Bartelink ML, van der Schouw YT, Bots ML.
  Hypertension. 2007 Apr;49(4):813-7.
  View

Insulin Sensitivity / Insulin Resistance

• Dissociation between metabolic and vascular insulin resistance in aging.
  Schulman IH, Zhou MS, Jaimes EA, Raij L.
  Am J Physiol Heart Circ Physiol. 2007 Apr 13
  View
• Alanine Aminotransferase (ALT) and Directly Measured Insulin Sensitivity in a Multi-ethnic Cohort The Insulin Resistance Atherosclerosis Study.
  Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM.
  Diabetes Care. 2007 Apr 11
  View

Non-Alcoholic Fatty Liver Disease

• Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
  Targher G, Arcaro G.
  Atherosclerosis. 2007 Apr;191(2):235-40.
  View
• The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the west.
  Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N.
  Dig Dis Sci. 2007 Apr 10
  View

Obesity

• Obesity, metabolic syndrome, and cardiovascular disease.
  Aggoun Y.
  Pediatr Res. 2007 Apr 5
  View
• Metabolic syndrome and gastrointestinal diseases.
  Watanabe S, Hojo M, Nagahara A.
  J Gastroenterol. 2007 Apr;42(4):267-74.
  View
• Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
  Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, Singh V, Taylor D, Vora J, Jones P.
  J Psychopharmacol. 2007 Apr 19
  View

PCOS / Menopause / Metabolic Syndrome in Women

• Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome.
  Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, De Lorenzo A, Tafuri D, Lombardi G, Colao A, Orio F.
  J Clin Endocrinol Metab. 2007 Apr;92(4):1379-84.
  View
• Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome.
  Sir-Petermann T, Echiburu B, Manuel Maliqueo M, Crisosto N, Sanchez F, Hitschfeld C, Carcamo M, Amigo P, Perez-Bravo F.
  Hum Reprod. 2007 Apr 27
  View
• The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): Prevalence of the metabolic syndrome in postmenopausal Latin American women.
  Izaguirre H, Ayala F, Martino M, Ojeda E, Onatra W, Saavedra J, Tserotas K, Pozzo E, Manriquez V, Prada M, Grandia E, Zuniga C, Lange D, Sayegh F, America FT.
  Climacteric. 2007 Apr;10(2):164-70.
  View
• Interrelationship between insulin resistance and menopause on the metabolic syndrome and its individual component among nondiabetic women in the Kinmen Study.
  Lin KC, Tsai ST, Kuo SC, Tsay SL, Chou P.
  Am J Med Sci. 2007 Apr;333(4):208-214.
  View

Pediatrics

• Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome.
  Brambilla P, Lissau I, Flodmark CE, Moreno LA, Widhalm K, Wabitsch M, Pietrobelli A.
  Int J Obes (Lond). 2007 Apr;31(4):591-600.
  View
• Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.
  de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, Tock L, Cristofalo DM, Lederman H, Tufik S, de Mello MT, Damaso AR.
  J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):446-52.
  View
• Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.
  McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing.
  Circulation. 2007 Apr 10;115(14):1948-67. Epub 2007 Mar 21.
  View

Prothrombotic State

• Hypertriglyceridemia: its etiology, effects and treatment.
  Yuan G, Al-Shali KZ, Hegele RA.
  CMAJ. 2007 Apr 10;176(8):1113-20.
  View

Risk Factors

• Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
  Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D.
  Am Heart J. 2007 Apr;153(4):552-8.
  View
• Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39.
  Ryu S, Song J, Choi BY, Lee SJ, Kim WS, Chang Y, Kim DI, Suh BS, Sung
  Ann Epidemiol. 2007 Apr;17(4):245-52.
  View
• Glomerular hyperfiltration: a new marker of metabolic risk.
  Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF.
  Kidney Int. 2007 Apr;71(8):816-21.
  View
• Metabolic risk factors and renal disease.
  Sowers JR.
  Kidney Int. 2007 Apr;71(8):719-20.
  View

Sleep Disorders

• Cardiovascular and metabolic effects of CPAP in obese males with OSA.
  Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM.
  Eur Respir J. 2007 Apr;29(4):720-7
  View
• The association of OSA with insulin resistance, inflammation and metabolic syndrome.
  Peled N, Kassirer M, Shitrit D, Kogan Y, Shlomi D, Berliner AS, Kramer MR.
  Respir Med. 2007 Apr 25
  View